CDKN1A and acute myeloid leukemia: Treatment of AML cell lines with the methylation inhibitor 5-Aza-2′-deoxycytidine (5-Aza-CdR) results in the induced p21Cip1/Waf expression by p73 demethylation, provoking a cell cycle arrest in the G1 phase (184, 185).